Brief: Bayer Completes Acquisition Of Perfuse Therapeutics
17/06/2026 07:32
BRIEF-Bayer Completes Acquisition Of Perfuse Therapeutics June 17 (Reuters) - BAYER AG BAYGn.DE:
BAYER COMPLETES ACQUISITION OF PERFUSE THERAPEUTICS
DEAL VALUED UP TO $2.45 BILLION WITH $300 MILLION UPFRONT PAYMENT
Source text: ID:nBw1NzYM5a
Further company coverage: [BAYGn.DE]
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 587785269;))
Recent news on Bayer AG
See all newsBrief: Bayer Says Finerenone Slowed Kidney Decline In CKD
Insight: How cheap Chinese antibiotics threaten Europe's last major penicillin plant
Deutsche Bank AG FF - Post Stabilisation Notice -Bayer EUR 30NC6 & 30NC9
Brief: Bayer To Present New Finerenone Data Across Chronic Kidney Disease With And Without Diabetes At Asn Kidney Week 2026
Brief: FDA Approves Once-Weekly Generic Hormone Therapy Patch For Women